Press Releases

Press Releases

May 31, 2018

Keystone Heart Ltd Announces First Enrollment in REFLECT Phase II incorporating TriGUARD 3™ Cerebral Embolic Protection device

CAESAREA, Israel and TAMPA, Fla., May 31, 2018 /PRNewswire/ -- Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection...
Read More
September 2, 2017

Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets

CAESAREA, Israel and TAMPA, Fla. and HANGZHOU, China, March 2, 2017 /PRNewswire/ -- Keystone Heart Ltd., a medical device company focused on developing cerebral embolic protection devices...
Read More
August 2, 2017

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

New third-generation cerebral embolic protection device offers improvements to further guard the brain from emboli during heart procedures including TAVR...
Read More
August 1, 2017

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

CAESAREA, Israel and TAMPA, Fla., Aug. 1, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for...
Read More
March 2, 2017

Keystone Heart und Venus Medtech erklären Zusammenarbeit beim Schutz vor Hirnembolie mit Transkatheter-Herzklappensystemen (TAVR) in China und asiatischen Schlüsselmärkten

Ankündigung geht Veröffentlichung neuer Leitlinien voraus, die auf notwendige zerebrale Protektion bei TAVR verweisen   CAESAREA, Israel, und TAMPA, Florida, und HANGZHOU,...
Read More
Triguard

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

Cerebral Embolic Protection Device

Stay Updated on the latest Blogs from Keystone Heart.

Skip to content